The methylphenidate patch (marketed under the brand name Daytrana) is licensed to treat attention deficit hyperactivity disorder (ADHD) in children and adolescents. The patch is applied once a day and can be worn for up to nine hours. Methylphenidate, which is a stimulant that produces a calming effect in children with ADHD, begins absorbing into the bloodstream through the skin approximately two hours after the patch is applied. Weight loss, insomnia, and vomiting are some of the more common side effects seen with the methylphenidate patch.
What Is the Methylphenidate Patch?
The methylphenidate patch (Daytrana™) is a prescription medication that is used for the treatment of attention deficit hyperactivity disorder (ADHD) in children and adolescents. It is a skin patch that is applied once daily (in the morning) and worn for nine hours, eliminating the need to take medication at school.
Methylphenidate is a stimulant that is commonly abused, so there are special rules for prescribing the methylphenidate patch (see Daytrana: A Controlled Substance).
Food and Drug Administration, Center for Drug Evaluation and Research. Electronic orange book: approved drug products with therapeutic equivalence evaluations. FDA Web site. Available at: http://www.fda.gov/cder/ob/. Accessed January 31, 2007.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind.
Site users seeking medical advice about their specific situation should consult with their own physician. Click